| Literature DB >> 27864367 |
Sheng Tao Hou1,2,3, Susan X Jiang2, L Irina Zaharia4, Xiumei Han4, Chantel L Benson4, Jacqueline Slinn2, Suzanne R Abrams4.
Abstract
Phaseic acid (PA) is a phytohormone regulating important physiological functions in higher plants. Here, we show the presence of naturally occurring (-)-PA in mouse and rat brains. (-)-PA is exclusively present in the choroid plexus and the cerebral vascular endothelial cells. Purified (-)-PA has no toxicity and protects cultured cortical neurons against glutamate toxicity through reversible inhibition of glutamate receptors. Focal occlusion of the middle cerebral artery elicited a significant induction in (-)-PA expression in the cerebrospinal fluid but not in the peripheral blood. Importantly, (-)-PA induction only occurred in the penumbra area, indicting a protective role of PA in the brain. Indeed, elevating the (-)-PA level in the brain reduced ischemic brain injury, whereas reducing the (-)-PA level using a monoclonal antibody against (-)-PA increased ischemic injury. Collectively, these studies showed for the first time that (-)-PA is an endogenous neuroprotective molecule capable of reversibly inhibiting glutamate receptors during ischemic brain injury.Entities:
Keywords: UPLC/MS/MS; abscisic acid (ABA); cerebral ischemia; choroid plexus; endothelial cells; neurochemistry; neurological disease; neuroprotection; phaseic acid; stroke
Mesh:
Substances:
Year: 2016 PMID: 27864367 PMCID: PMC5207134 DOI: 10.1074/jbc.M116.756429
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157